Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
about
Biomarkers and Targeted Therapy in Pancreatic CancerCan Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cellsKRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment.Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens.Molecular driver alterations and their clinical relevance in cancer of unknown primary site.Papanicolaou Society of Cytopathology new guidelines have a greater ability of risk stratification for pancreatic endoscopic ultrasound-guided fine-needle aspiration specimens.Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression.Second line treatment options for pancreatic cancer.Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancerMicroRNA in pancreatic cancer.Targeting reactive oxygen species in development and progression of pancreatic cancer.Molecular imaging and cancer gene therapy.Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.Independent and core pathways in oncogenic KRAS signaling.BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity.Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome.Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP.Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy.Genetics of pancreatic cancer and implications for therapy.Commentary: Pancreatic cancer: is the worst to come?Pancreatic cancer: Exosomes for targeting KRAS in the treatment of pancreatic cancer.Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates.Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice.In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant antigens
P2860
Q26752755-7528F336-CBC7-43CC-B8B8-3A296B3D4900Q28066454-57B90EDE-86FC-4DDF-B2BF-C58E9A3593EEQ28468669-AAD43B64-C10F-49D2-88B2-E61EE30EFF51Q33591865-5C18B06F-8B33-4A7A-AEBB-BBE32BD9ECCDQ33624574-6990D00D-CB2D-49E3-BF36-C1A387C5FFF6Q33838679-E06C72F3-ADE4-44BE-85CD-78348B5CA30DQ33914197-9F0B52B2-12F7-409D-B98F-DC3ED0553120Q36261430-EF75FD70-102E-4140-9388-3DC143C63149Q37536877-90116261-EAC6-4955-A388-8567027C8DC9Q37702678-2EB8C255-FF02-462D-8BF5-14CC6554F737Q37707088-9B0EECD8-84C5-4CAE-B6DF-59716D30D19EQ38640398-5346B66E-A29D-4881-97DA-A1D086F0ACACQ38748709-E9B3838C-1EA0-4329-BCF2-A16C4A39F554Q38850617-336034B2-40D1-4EF6-B88C-211280C966D5Q39007517-30AFB591-5524-47F4-9458-E9B9B6681580Q39011437-76CDCA59-47DA-4AFD-A710-E86D2B3A4A19Q39070481-F5C8409A-8D7B-4CE3-9AB6-5CBA18CC60B6Q39359422-D50A49D8-B17D-44BF-8E93-070A85EA76E2Q40968374-BE043F19-0B7E-475C-9DD3-2F0CE7C3F35EQ41280277-874FB9E4-D81D-4427-AC9D-B518E0ECD353Q45249684-5748C03D-6FA0-4971-8A06-C4A8F6266D6DQ45559181-5C0C0E4F-9F2F-4F30-86A2-1806C703B178Q47735303-23F5828E-7F13-4647-8DFF-7075D39F2B13Q49606173-3E39A6F3-FD49-45D0-BC36-CA7FC1A4246BQ50100064-75EBF6FE-537E-48CE-9DD1-8538FBEA857DQ50218950-EFDAD3A0-09B4-4FEE-8E0B-13E29D3B071CQ53112953-27A9B300-591F-4019-AFC1-A1D54EE1EE88Q55513822-32F78D3C-0931-4D24-9657-AC8B5DF06F07Q57175287-879C3AE1-1929-4614-8D03-E45E39E497F6
P2860
Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting KRAS for diagnosis, ...... c cancer: Hopes and realities.
@en
type
label
Targeting KRAS for diagnosis, ...... c cancer: Hopes and realities.
@en
prefLabel
Targeting KRAS for diagnosis, ...... c cancer: Hopes and realities.
@en
P2093
P1476
Targeting KRAS for diagnosis, ...... ic cancer: Hopes and realities
@en
P2093
Barbara Bournet
Camille Buscail
Louis Buscail
P356
10.1016/J.EJCA.2015.11.012
P577
2015-12-28T00:00:00Z